Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 84, Issue 3, 2001, Pages

  Hirano, K ^a   Morinobu, T ^a   Kim, H ^a   Hiroi, M ^a   Ban, R ^a   Ogawa, S ^a   Ogihara, H ^a   Tamai, H ^a   Ogihara, T ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Ascorbic acid; Blood transfusion; Chronic lung disease; Iron; Preterm; Retinopathy of prematurity

Indexed keywords

ASCORBIC ACID; DEHYDROASCORBIC ACID; DNA; FERROUS ION; IRON; TRANSFERRIN;

ANEMIA; ARTICLE; CLINICAL ARTICLE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INFANT; IRON BLOOD LEVEL; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RISK FACTOR; VITAMIN BLOOD LEVEL;

EID: 0035010419     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.84.3.f188     Document Type: Article

References (38)

1. Retrolental fibroplasia and blood transfusion in very low-birth-weight infants
2. Blood transfusion: A possible risk factor in retrolental fibroplasia
3. Retinopathy of prematurity: Incidence and risk factors
4. Blood transfusion and chronic lung disease in preterm infants
5. Antioxidant activity, packed cell transfusions, and outcome in premature infants
6. The life span of erythrocytes transfused to preterm infants
7. Oxygen toxicity in the neonatal period
8. New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease
9. Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease
10. Susceptibility of neonatal lipoproteins to oxidative stress
11. Bilirubin and ascorbate antioxidant activity in neonatal plasma
12. Developmental patterns of antioxidant defense mechanisms in human erythrocytes
13. Bleomycin-detectable iron in the plasma of premature and full-term neonates
14. Role of free radicals and catalytic metal ions in human disease: An overview
15. Vitamin C: Antioxidant or pro-oxidant in vivo?
16. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts: Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA
17. Iron complexes and their reactivity in the bleomycin assay for radical-promoting loosely-bound iron
18. Epidemiology of neonatal chronic lung disease in Japan
19. An international classification of retinopathy of prematurity
20. Development of additive solution MAP for storage of red cell concentrates
21. Ferrous ions detected in cerebrospinal fluid by using bleomycin and DNA damage
22. A micromethod for determination of ferroxidase (ceruloplasmin) in human plasma
23. A sensitive, direct colorimetric assay of serum iron using the chromogen, nitro-PAPS
24. Oxidation products of uric acid and ascorbic acid in preterm infants with chronic lung disease
25. Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity'
26. Retinopathy of prematurity: Low iron binding capacity may contribute
27. Blood transfusion: Iron load and retinothy of prematurity
28. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity
29. Iron absorption by the preterm infant. The effect of transfusion and iron supplements on the serum ferritin levels
30. Chromatographic method for the determination of non-transferrin-bound iron suitable for use on the plasma and bronchoalveolar lavage fluid of preterm babies
31. Nonprotein-bound iron in postasphyxial reperfusion injury of the newborn
32. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity
33. Antioxidant activity of vitamin C in iron-overloaded human plasma
34. Ferrous ions detected in iron-overloaded cord blood plasma from preterm and term babies: Implications for oxidative stress
35. Caeruloplasmin: Physiological and pathological perspectives
36. Plasma ascorbate levels and inhibition of the antioxidant activity of caeruloplasmin
37. Oxidants as stimulators of signal transduction
38. Oxidative damage and fibrogenesis